News Sentiment

MAZE sentiment intelligence

Maze Therapeutics, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 52 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 30.57 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-2.2% over one week, +27.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

$MAZE stock is down 10% today. Here's what we see in our data.

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -2.2% Price reacting lower
Trend fit Trend inactive 27.1% over four weeks
Fair value 23.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 40
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
Market source 10
TradingView 10
Quiver Quantitative 3
Investing.com 2
simplywall.st 2
Seeking Alpha 2
TIKR.com 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 19
Balance sheet 1
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-52 of 52